ReviewCancer control : journal of the Moffitt Cancer Center
Prognostic Biomarkers for Hepatocellular Carcinoma Patients Treated With Atezolizumab plus Bevacizumab Combination Therapy.
Long-Bin Jeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.